---
title: "Prevalence and drivers of functional difficulty in Ethiopian children aged 5–17: 2024–25 EDHS anal"
id: "medrxiv-21-functional-difficulty-among-children-and-adolescents-aged-5-17-years-in"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-21-functional-difficulty-among-children-and-adolescents-aged-5-17-years-in"
content_type: "clinical_feed_article"
specialty: "Pediatrics"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.09.26367692v1?rss=1"
published_at: "2026-11-11T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Prevalence and drivers of functional difficulty in Ethiopian children aged 5–17: 2024–25 EDHS anal
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-21-functional-difficulty-among-children-and-adolescents-aged-5-17-years-in
- **Specialty:** [Pediatrics](https://medichelpline.com/clinical-feed/pediatrics.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.09.26367692v1?rss=1)
- **Published At:** 2026-11-11T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The 2024–2025 Ethiopia Demographic and Health Survey (EDHS) included the **UNICEF/Washington Group Child Functioning Module** for ages 5–17 for the first time, enabling population-level estimates. - Investigators analysed cross-sectional data on 11,122 children (weighted n = 10,726) and 4,739 mothers; functional difficulty was defined as “a lot of difficulty” or “cannot do at all” in any of 11 domains, or daily anxiety or depression. - Design-based prevalence for any functional difficulty was 9.5% (95% CI 8.1–11.1); affective symptoms dominated: daily depression 6.8% and daily anxiety 6.6%. - Seventy per cent of affected children had affective-only difficulty; non-affective domains affected 2.8% overall, with individual non-affective domains at 0.5–1.4%. - Geographic variation was marked: prevalence ranged from 1.5% in Southwest Regional State to 16.5% in Oromia Regional State. - Multilevel logistic models (children nested within mothers within clusters) linked non-attendance at school with higher odds of non-affective difficulty (AOR 2.82, 95% CI 2.01–3.96); girls had lower odds (AOR 0.63, 0.48–0.84). - Outcomes clustered strongly: sibling correlation 67.7% and cluster-level intraclass correlation 20.9%, indicating family and community aggregation. - Interviewer effects were substantial: six interviewers accounted for 58.2% of weighted cases of daily anxiety or depression; within the same clusters other interviewers recorded 2.1% daily symptoms. - Excluding 11 statistical outlier interviewers reduced estimated prevalence to 4.6% for any difficulty and to 3.3% for daily anxiety or depression, while core associations (school non-attendance, sex) remained. - The authors provided analysis code and record-linkage details in Additional file 2 and note DHS datasets are available on registration from the DHS Program.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=j2FAtvPhvtCgG6ncr2tpZRJ8Ga8iWv.yJdEcMkex2tI-1794427622.4045234-1.2.1.1-WYtNZgkqGXzqZ1MaZKLfNRpckZ.s.jXebQqCNh.AtKFtq1NYdwHak9msB1l53cXd) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.09.26367692v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Functional difficulty among children and adolescents aged 5-17 years in Ethiopia: Multilevel analysis of the nationally representative 2024-2025 DHS Mahder Dereb Hailemariam, Awoke MIHRETU SISAYE Sisaye doi: https://doi.org/10.64898/2026.11.09.26367692 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Mahder Dereb Hailemariam ADDIS ABABA UNIVERSITY * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mahder%2BDereb%2BHailemariam%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hailemariam%20MD&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMahder%2BDereb%2BHailemariam%2B) Awoke MIHRETU SISAYE Sisaye ADDIS ABABA UNIVERSITY * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Awoke%2BMIHRETU%2BSISAYE%2BSisaye%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sisaye%20AM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAwoke%2BMIHRETU%2BSISAYE%2BSisaye%2B) * For correspondence: awoke.mihretu@aau.edu.et * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.09.26367692v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1342492/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.09.26367692v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1342492/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.09.26367692v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1342492/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.09.26367692v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1342492/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.09.26367692v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1342492/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Population-based data on functional difficulty among school-age children in Ethiopia are scarce. The 2024-2025 Ethiopia Demographic and Health Survey (EDHS) included, for the first time, the UNICEF/Washington Group Child Functioning Module (CFM) for children aged 5-17 years. We estimated the prevalence and domain distribution of functional difficulty and associated factors in Ethiopia. Methods: We analysed cross-sectional EDHS data from 11,122 children aged 5-17 years (weighted n = 10,726) and 4,739 mothers. Functional difficulty was defined as "a lot of difficulty" or "cannot do at all" in any of 11 domains, or daily anxiety or depression. We estimated design-based prevalence and fitted multilevel logistic regression models (children within mothers within clusters) for any, non-affective and affective difficulty. Interviewer effects were examined with random-intercept models and within-cluster comparisons. Results: Overall, 9.5% (95% CI 8.1-11.1) of children had functional difficulty. Daily depression (6.8%) and anxiety (6.6%) dominated, and 70.3% of affected children had only affective difficulty. Difficulty in at least one non-affective domain affected 2.8% (2.2-3.7), with each domain at 0.5-1.4%. Prevalence ranged from 1.5% in Southwest Regional State, Ethiopia, to 16.5% in Oromia Regional State. In adjusted models, children not attending school had higher odds of non-affective difficulty (AOR 2.82, 95% CI 2.01-3.96), and girls had lower odds (AOR 0.63, 0.48-0.84). Outcomes clustered strongly within families (sibling correlation 67.7%) and clusters (ICC 20.9%). Six of 163 interviewers (7.9% of the weighted sample) contributed 58.2% of weighted cases of daily anxiety or depression; in the same clusters they recorded daily symptoms for 56.4% of children, against 2.1% for other interviewers. Excluding 11 statistically outlying interviewers reduced the prevalence of any difficulty to 4.6% (3.6-5.8) and of daily anxiety or depression to 3.3%. The associations with school non-attendance and sex were unchanged. Conclusions: Functional difficulties across the sensory, physical, cognitive, and affective domains, including anxiety or depression, affect about 2-3% of Ethiopian children aged 5-17 years and are strongly associated with being out of school. Appropriate interventions and resource allocation should be considered. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The datasets are available from the DHS Program (https://dhsprogram.com). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability Availability of data and materials: The datasets are available from the DHS Program (https://dhsprogram.com) on registration. Analysis code, including the record-linkage procedure, is provided in Additional file 2. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.09.26367692v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.10.26367717v1 "Electromechanical Drivers of Diastolic Dysfunction During Hypertrophic Cardiomyopathy Progression")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.10.26367534v1 "Comprehensive proteomics reveals stage-specific signatures in blood that precede diabetic kidney disease onset and progression") Posted November 11, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.09.26367692v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/11/2026.11.09.26367692.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.09.26367692v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/11/2026.11.09.26367692.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Functional difficulty among children and adolescents aged 5-17 years in Ethiopia: Multilevel analysis of the nationally representative 2024-2025 DHS Mahder Dereb Hailemariam, Awoke MIHRETU SISAYE Sisaye medRxiv 2026.11.09.26367692; doi: https://doi.org/10.64898/2026.11.09.26367692 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367692v1%26text%3DFunctional%2520difficulty%2520among%2520children%2520and%2520adolescents%2520aged%25205-17%2520years%2520in%2520Ethiopia%253A%2520Multilevel%2520analysis%2520of%2520the%2520nationally%2520representative%25202024-2025%2520DHS "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367692v1%26t%3DFunctional%2520difficulty%2520among%2520children%2520and%2520adolescents%2520aged%25205-17%2520years%2520in%2520Ethiopia%253A%2520Multilevel%2520analysis%2520of%2520the%2520nationally%2520representative%25202024-2025%2520DHS "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367692v1%26title%3DFunctional%2520difficulty%2520among%2520children%2520and%2520adolescents%2520aged%25205-17%2520years%2520in%2520Ethiopia%253A%2520Multilevel%2520analysis%2520of%2520the%2520nationally%2520representative%25202024-2025%2520DHS%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.09.26367692v1%26title%3DFunctional%2520difficulty%2520among%2520children%2520and%2520adolescents%2520aged%25205-17%2520years%2520in%2520Ethiopia%253A%2520Multilevel%2520analysis%2520of%2520the%2520nationally%2520representative%25202024-2025%2520DHS "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.09.26367692) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (638) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (919) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (352) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5016) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (429) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (679) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1695) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16282) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1242) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7289) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (753) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1095) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5303) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1474) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1836) * [Hematology](https://www.medrxiv.org/collection/hematology) (599) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1383) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16501) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1203) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (701) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (754) * [Neurology](https://www.medrxiv.org/collection/neurology) (7616) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1132) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1296) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1041) * [Oncology](https://www.medrxiv.org/collection/oncology) (3751) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1096) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (411) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (466) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (502) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (143) * [Pathology](https://www.medrxiv.org/collection/pathology) (721) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1864) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (757) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (786) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6149) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10010) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2540) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1524) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1271) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (663) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (805) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (598) * [Surgery](https://www.medrxiv.org/collection/surgery) (806) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (320) * [Urology](https://www.medrxiv.org/collection/urology) (308) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of the authors. Video: _There are no videos for this paper._ Powered by [![Hypothes.is logo](https://connect.biorxiv.org/eval/hypothesis.png)](https://web.hypothes.is/) Powered by [![Altmetric logo](https://connect.biorxiv.org/eval/altmetric.png)](https://www.altmetric.com/) ## Follow this preprint X You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the [medRxiv Alerts Page](https://medrxiv.org/alerts). Sign In to Follow this Preprint Email * Email this Articleclose Thank you for your interest in spreading the w
## Related Clinical Research

- [Parental Nativity and Adolescent Mental Health in the US: NHIS 2022–2024 Analysis](https://medichelpline.com/clinical-feed/medrxiv-9-association-between-parental-nativity-and-mental-health-among-u-s-adolescents.md)
- [Longitudinal links between pain and anxiety/depression in young people: systematic review and meta](https://medichelpline.com/clinical-feed/medrxiv-10-temporal-associations-between-pain-and-anxiety-depression-in-young-people-a.md)
- [Child Health as a National Security Threat: How Pediatric Decline Undermines Readiness and Workfor](https://medichelpline.com/clinical-feed/stat-news-4-opinion-child-health-is-the-national-security-crisis-we-keep-ignoring.md)
- [Physical activity intensity linked to lower self-reported emphysema in older US adults (NHANES ana](https://medichelpline.com/clinical-feed/plos-one-5-association-between-physical-activity-intensity-and-self-reported-emphysema-a.md)
- [Diabetic ketoacidosis admissions fell 6.9% annually in a 10-year Norwegian cohort](https://medichelpline.com/clinical-feed/plos-one-18-trends-and-outcomes-in-diabetic-ketoacidosis-a-10-year-retrospective-study-at-a.md)

## Navigation
- [← Back to Pediatrics Feed](https://medichelpline.com/clinical-feed/pediatrics.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.